"OK, let's get to your and DRX fixation on news and SEC

New Post Public Reply Private Reply Replies (3) Message Board
Djpele Puravida19 #20244
473
Quote:
"OK, let's get to your and DRX fixation on news and SEC reporting. When the SEC noticed the company, Squires said the company was hiring SEC knowledgeable attorneys. I presume that happened and we have to wait and see what happens."


How do you explain the fact QMC has still not responded to the SEC? On June 3rd, QMC stated this in their press release:

Quote:
"The Company has retained securities counsel who have communicated with the SEC and is exploring the most efficient way that it can once again become a current reporting company with the Commission."


Yet, the SEC on July 2nd filed this:

Quote:
"On June 2, 2021, the Division of Enforcement filed the Declaration of Sandhya C. Harris, which established that, pursuant to Commission Rule of Practice 141(a)(2)(ii),
2 service of the OIP was made on Respondent on May 15, 2021. As stated in the OIP, Respondent’s answer was required to be filed within ten days of service of the OIP.3 As of the date of this order, Respondent has not filed an answer.
4 The prehearing conference and the hearing are thus continued indefinitely."


This is also after QMC filed their latest 10-Q on June 24th stating they will voluntarily revoke themselves:

Quote:
Following the filing of this Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2019, the Company will be entering into an Offer of Settlement with the SEC which will result in the revocation of the registration of Company’s securities pursuant to Section 12 of the Exchange Act, thereby terminating the Company Section 12(g) reporting obligations with the SEC.


Why is the company making it appear that they have been communicating with the SEC, when the SEC themselves are stating that they haven't heard from them?

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
My posts is of my opinion only. Please conduct your own Due Diligence; this is YOUR investment.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Oscar Health Options Activity and Market Insights for Investors

Updated Category News Views 265

Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...

Continue Reading
Better Choice Company Finalizes Sale of Halo Asia Business

Updated Category News Views 160

Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....

Continue Reading
Fastenal Prepares for Earnings Report: What Investors Should Know

Updated Category News Views 154

Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....

Continue Reading
Compass Therapeutics Takes Major Steps in Biliary Cancer Trials

Updated Category News Views 203

Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...

Continue Reading
Understanding the Recent ECB Fine on LHV Group and Its Implications

Updated Category News Views 218

Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...

Continue Reading